Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: GENOMIC HEALTH, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-03-13 to 2025-10-31
Current total value of award: $335034.12
Description: ONCOTYPE DX TESTING FUND OPT IV - FY24 FUNDS